> top > docs > PMC:3312845 > spans > 8167-9312 > annotations

PMC:3312845 / 8167-9312 JSONTXT

Annnotations TAB JSON ListView MergeView

2_test

Id Subject Object Predicate Lexical cue
22240205-16845674-63147415 625-627 16845674 denotes 25

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T4172 1143-1144 -RRB- denotes )
T4171 1142-1143 CD denotes 7
T4170 1140-1141 SYM denotes =
T4169 1138-1139 NN denotes n
T4168 1137-1138 -LRB- denotes (
T4167 1128-1136 NN denotes controls
T4166 1125-1127 IN denotes as
T4165 1120-1124 VB denotes used
T4164 1115-1119 VB denotes were
T4163 1110-1114 NN denotes rats
T4162 1103-1109 JJ denotes normal
T4161 1091-1102 JJ denotes age-matched
T4160 1087-1090 CC denotes and
T4159 1085-1086 -RRB- denotes )
T4158 1084-1085 CD denotes 8
T4157 1082-1083 SYM denotes =
T4156 1080-1081 NN denotes n
T4155 1078-1079 -COMMA- denotes ,
T4154 1075-1078 NN denotes min
T4153 1072-1074 CD denotes 30
T4152 1070-1071 -COLON- denotes -
T4151 1067-1069 CD denotes 10
T4150 1060-1066 IN denotes during
T4149 1050-1059 NN denotes behaviors
T4148 1042-1049 NN denotes seizure
T4147 1036-1041 JJ denotes acute
T4146 1031-1035 RB denotes only
T4145 1023-1030 VB denotes showing
T4144 1022-1023 -LRB- denotes (
T4143 1017-1021 NN denotes rats
T4142 1015-1016 -RRB- denotes )
T4141 1009-1015 JJ denotes non-SE
T4140 1008-1009 -LRB- denotes (
T4139 1005-1007 NN denotes SE
T4138 989-1004 JJ denotes Non-experienced
T4137 979-987 NN denotes seizures
T4136 967-978 JJ denotes spontaneous
T4135 964-966 IN denotes of
T4134 953-963 NN denotes occurrence
T4133 949-952 CC denotes and
T4132 940-948 NN denotes behavior
T4131 932-939 JJ denotes general
T4130 928-931 IN denotes for
T4129 919-927 NN denotes vivarium
T4128 915-918 DT denotes the
T4127 912-914 IN denotes in
T4126 908-911 NN denotes day
T4125 906-907 DT denotes a
T4124 900-905 NN denotes hours
T4123 898-899 CD denotes 4
T4122 896-897 -COLON- denotes -
T4121 894-895 CD denotes 3
T4120 885-893 VB denotes observed
T4119 880-884 RB denotes then
T4118 875-879 VB denotes were
T4117 870-874 NN denotes rats
T4116 866-869 DT denotes The
T4115 858-864 VB denotes needed
T4114 855-857 IN denotes as
T4113 853-854 -COMMA- denotes ,
T4112 845-853 VB denotes repeated
T4111 841-844 CC denotes and
T4110 838-840 NN denotes SE
T4109 835-837 IN denotes of
T4108 829-834 NN denotes onset
T4107 823-828 IN denotes after
T4106 817-822 NN denotes hours
T4105 815-816 CD denotes 2
T4104 802-814 VB denotes administered
T4103 798-801 VB denotes was
T4102 796-797 -RRB- denotes )
T4101 787-796 NN denotes sur-Seine
T4100 779-786 NNP denotes Neuilly
T4099 777-778 -COMMA- denotes ,
T4098 772-777 NNP denotes Roche
T4097 769-771 NNP denotes Ia
T4096 761-768 NNP denotes Hoffman
T4095 759-760 -COLON- denotes ;
T4094 755-759 RB denotes i.p.
T4093 753-754 -COMMA- denotes ,
T4092 748-753 NN denotes mg/kg
T4091 745-747 CD denotes 10
T4090 744-745 -LRB- denotes (
T4089 735-743 NN denotes Diazepam
T4088 722-733 NN denotes epilepticus
T4087 715-721 NN denotes status
T4086 695-714 JJ denotes pilocarpine-induced
T4085 689-694 IN denotes after
T4084 682-688 NN denotes months
T4083 678-681 CD denotes 1-3
T4082 671-677 IN denotes within
T4081 662-670 NN denotes seizures
T4080 652-661 JJ denotes recurrent
T4079 650-651 -COMMA- denotes ,
T4078 639-650 JJ denotes spontaneous
T4077 629-638 VB denotes displayed
T4076 627-628 -RRB- denotes ]
T4075 625-627 CD denotes 25
T4074 624-625 -LRB- denotes [
T4073 616-623 NN denotes studies
T4072 607-615 JJ denotes previous
T4071 603-606 PRP-DOLLAR- denotes our
T4070 600-602 IN denotes in
T4069 590-599 VB denotes monitored
T4068 587-589 PRP denotes we
T4067 582-586 IN denotes that
T4066 577-581 NN denotes rats
T4065 573-576 DT denotes the
T4064 570-572 IN denotes of
T4063 568-569 NN denotes %
T4062 566-568 CD denotes 90
T4061 564-565 JJ denotes >
T4060 556-563 IN denotes because
T4059 554-555 -COMMA- denotes ,
T4058 549-554 NN denotes model
T4057 545-548 NN denotes rat
T4056 539-544 NN denotes hr-SE
T4055 537-538 CD denotes 2
T4054 533-536 DT denotes the
T4053 525-532 VB denotes applied
T4052 522-524 PRP denotes We
T4051 519-520 -RRB- denotes )
T4050 512-519 VB denotes falling
T4049 508-511 CC denotes and
T4048 506-507 -COMMA- denotes ,
T4047 497-506 NN denotes movements
T4046 493-496 NN denotes jaw
T4045 481-492 JJ denotes masticatory
T4044 479-480 -COMMA- denotes ,
T4043 469-479 NN denotes salivation
T4042 467-468 -COMMA- denotes ,
T4041 460-467 VB denotes rearing
T4040 455-459 IN denotes with
T4039 448-454 NN denotes clonus
T4038 439-447 NN denotes forelimb
T4037 436-438 IN denotes of
T4036 425-435 VB denotes consisting
T4035 416-424 NN denotes seizures
T4034 409-415 JJ denotes limbic
T4033 407-408 -COMMA- denotes ,
T4032 396-407 NN denotes automatisms
T4031 389-395 JJ denotes facial
T4030 387-388 -COMMA- denotes ,
T4029 379-387 NN denotes akinesia
T4028 369-378 VB denotes including
T4027 368-369 -LRB- denotes (
T4026 365-367 NN denotes SE
T4025 362-364 IN denotes of
T4024 353-361 NN denotes features
T4023 342-352 JJ denotes behavioral
T4022 336-341 JJ denotes acute
T4021 329-335 VB denotes showed
T4020 324-328 NN denotes rats
T4019 316-323 VB denotes treated
T4018 304-315 NN denotes pilocarpine
T4017 301-303 IN denotes of
T4016 299-300 NN denotes %
T4015 297-299 CD denotes 80
T4014 283-296 RB denotes Approximately
T4013 278-281 NN denotes min
T4012 272-277 CD denotes 20-40
T4011 265-271 IN denotes within
T4010 259-264 VB denotes began
T4009 249-258 RB denotes typically
T4008 240-248 NN denotes seizures
T4007 229-239 JJ denotes behavioral
T4006 227-228 -COMMA- denotes ,
T4005 219-227 NN denotes paradigm
T4004 209-218 NN denotes treatment
T4003 204-208 DT denotes this
T4002 198-203 VB denotes Using
T4001 195-196 -RRB- denotes )
T4000 193-195 NN denotes MO
T3999 191-192 -COMMA- denotes ,
T3998 186-191 NNP denotes Louis
T3997 182-185 NNP denotes St.
T3996 180-181 -COMMA- denotes ,
T3995 177-180 NNP denotes Co.
T3994 163-176 NNP denotes Sigma-Aldrich
T3993 161-162 -COLON- denotes ;
T3992 157-161 RB denotes i.p.
T3991 155-156 -COMMA- denotes ,
T3990 150-155 NN denotes mg/kg
T3989 148-149 CD denotes 5
T3988 147-148 -LRB- denotes (
T3987 129-146 NN denotes methylscopolamine
T3986 123-128 IN denotes after
T3985 119-122 NN denotes min
T3984 116-118 CD denotes 20
T3983 113-115 IN denotes at
T3982 111-112 -RRB- denotes )
T3981 109-111 NN denotes MO
T3980 107-108 -COMMA- denotes ,
T3979 102-107 NNP denotes Louis
T3978 98-101 NNP denotes St.
T3977 96-97 -COMMA- denotes ,
T3976 93-96 NNP denotes Co.
T3975 79-92 NNP denotes Sigma-Aldrich
T3974 77-78 -COLON- denotes ;
T3973 73-77 RB denotes i.p.
T3972 71-72 -COMMA- denotes ,
T3971 66-71 NN denotes mg/kg
T3970 62-65 CD denotes 380
T3969 61-62 -LRB- denotes (
T3968 49-60 NN denotes pilocarpine
T3967 44-48 IN denotes with
T3966 36-43 VB denotes treated
T3965 31-35 VB denotes were
T3964 26-30 NN denotes rats
T3963 24-25 -COMMA- denotes ,
T3962 17-24 NN denotes surgery
T3961 11-16 IN denotes after
T3960 6-10 NN denotes days
T3959 0-5 CD denotes Three
R3029 T3960 T3959 arg1Of days,Three
R3030 T3961 T3960 arg1Of after,days
R3031 T3962 T3961 arg2Of surgery,after
R3032 T3964 T3965 arg1Of rats,were
R3033 T3964 T3966 arg2Of rats,treated
R3034 T3966 T3961 arg1Of treated,after
R3035 T3966 T3963 arg1Of treated,","
R3036 T3966 T3965 arg2Of treated,were
R3037 T3966 T3967 arg1Of treated,with
R3038 T3968 T3967 arg2Of pilocarpine,with
R3039 T3968 T3969 arg1Of pilocarpine,(
R3040 T3968 T3988 arg1Of pilocarpine,(
R3041 T3969 T3983 arg1Of (,at
R3042 T3971 T3970 arg1Of mg/kg,380
R3043 T3971 T3972 arg1Of mg/kg,","
R3044 T3971 T3973 arg1Of mg/kg,i.p.
R3045 T3971 T3974 arg1Of mg/kg,;
R3046 T3974 T3977 arg1Of ;,","
R3047 T3976 T3974 arg2Of Co.,;
R3048 T3976 T3975 arg1Of Co.,Sigma-Aldrich
R3049 T3977 T3969 arg2Of ",",(
R3050 T3977 T3980 arg1Of ",",","
R3051 T3977 T3981 arg1Of ",",MO
R3052 T3979 T3977 arg2Of Louis,","
R3053 T3979 T3978 arg1Of Louis,St.
R3054 T3982 T3969 arg3Of ),(
R3055 T3985 T3983 arg2Of min,at
R3056 T3985 T3984 arg1Of min,20
R3057 T3985 T3986 arg1Of min,after
R3058 T3987 T3986 arg2Of methylscopolamine,after
R3059 T3990 T3989 arg1Of mg/kg,5
R3060 T3990 T3991 arg1Of mg/kg,","
R3061 T3990 T3992 arg1Of mg/kg,i.p.
R3062 T3990 T3993 arg1Of mg/kg,;
R3063 T3993 T3996 arg1Of ;,","
R3064 T3995 T3993 arg2Of Co.,;
R3065 T3995 T3994 arg1Of Co.,Sigma-Aldrich
R3066 T3996 T3988 arg2Of ",",(
R3067 T3996 T3999 arg1Of ",",","
R3068 T3998 T3996 arg2Of Louis,","
R3069 T3998 T3997 arg1Of Louis,St.
R3070 T4000 T3999 arg2Of MO,","
R3071 T4001 T3988 arg3Of ),(
R3072 T4005 T4002 arg2Of paradigm,Using
R3073 T4005 T4003 arg1Of paradigm,this
R3074 T4005 T4004 arg1Of paradigm,treatment
R3075 T4008 T4002 arg1Of seizures,Using
R3076 T4008 T4007 arg1Of seizures,behavioral
R3077 T4008 T4010 arg1Of seizures,began
R3078 T4010 T4002 modOf began,Using
R3079 T4010 T4006 arg1Of began,","
R3080 T4010 T4009 arg1Of began,typically
R3081 T4010 T4011 arg1Of began,within
R3082 T4013 T4011 arg2Of min,within
R3083 T4013 T4012 arg1Of min,20-40
R3084 T4015 T4014 arg1Of 80,Approximately
R3085 T4016 T4015 arg1Of %,80
R3086 T4016 T4017 arg1Of %,of
R3087 T4016 T4021 arg1Of %,showed
R3088 T4020 T4017 arg2Of rats,of
R3089 T4020 T4018 arg1Of rats,pilocarpine
R3090 T4020 T4019 arg2Of rats,treated
R3091 T4024 T4021 arg2Of features,showed
R3092 T4024 T4022 arg1Of features,acute
R3093 T4024 T4023 arg1Of features,behavioral
R3094 T4024 T4025 arg1Of features,of
R3095 T4024 T4027 arg1Of features,(
R3096 T4026 T4025 arg2Of SE,of
R3097 T4028 T4027 arg2Of including,(
R3098 T4029 T4030 arg1Of akinesia,","
R3099 T4030 T4033 arg1Of ",",","
R3100 T4032 T4030 arg2Of automatisms,","
R3101 T4032 T4031 arg1Of automatisms,facial
R3102 T4033 T4028 arg2Of ",",including
R3103 T4033 T4036 arg1Of ",",consisting
R3104 T4035 T4033 arg2Of seizures,","
R3105 T4035 T4034 arg1Of seizures,limbic
R3106 T4036 T4037 arg1Of consisting,of
R3107 T4039 T4038 arg1Of clonus,forelimb
R3108 T4039 T4040 arg1Of clonus,with
R3109 T4039 T4044 arg1Of clonus,","
R3110 T4041 T4042 arg1Of rearing,","
R3111 T4042 T4040 arg2Of ",",with
R3112 T4043 T4042 arg2Of salivation,","
R3113 T4044 T4049 arg1Of ",",and
R3114 T4047 T4044 arg2Of movements,","
R3115 T4047 T4045 arg1Of movements,masticatory
R3116 T4047 T4046 arg1Of movements,jaw
R3117 T4049 T4037 arg2Of and,of
R3118 T4049 T4048 arg1Of and,","
R3119 T4050 T4049 arg2Of falling,and
R3120 T4051 T4027 arg3Of ),(
R3121 T4052 T4053 arg1Of We,applied
R3122 T4053 T4059 arg1Of applied,","
R3123 T4053 T4060 arg1Of applied,because
R3124 T4058 T4053 arg2Of model,applied
R3125 T4058 T4054 arg1Of model,the
R3126 T4058 T4055 arg1Of model,2
R3127 T4058 T4056 arg1Of model,hr-SE
R3128 T4058 T4057 arg1Of model,rat
R3129 T4062 T4061 arg1Of 90,>
R3130 T4063 T4062 arg1Of %,90
R3131 T4063 T4064 arg1Of %,of
R3132 T4063 T4074 arg1Of %,[
R3133 T4063 T4077 arg1Of %,displayed
R3134 T4066 T4064 arg2Of rats,of
R3135 T4066 T4065 arg1Of rats,the
R3136 T4066 T4067 arg1Of rats,that
R3137 T4066 T4069 arg2Of rats,monitored
R3138 T4068 T4069 arg1Of we,monitored
R3139 T4069 T4070 arg1Of monitored,in
R3140 T4073 T4070 arg2Of studies,in
R3141 T4073 T4071 arg1Of studies,our
R3142 T4073 T4072 arg1Of studies,previous
R3143 T4075 T4074 arg2Of 25,[
R3144 T4076 T4074 arg3Of ],[
R3145 T4077 T4060 arg2Of displayed,because
R3146 T4078 T4079 arg1Of spontaneous,","
R3147 T4080 T4079 arg2Of recurrent,","
R3148 T4081 T4077 arg2Of seizures,displayed
R3149 T4081 T4078 arg1Of seizures,spontaneous
R3150 T4081 T4080 arg1Of seizures,recurrent
R3151 T4081 T4082 arg1Of seizures,within
R3152 T4084 T4082 arg2Of months,within
R3153 T4084 T4083 arg1Of months,1-3
R3154 T4084 T4085 arg1Of months,after
R3155 T4088 T4085 arg2Of epilepticus,after
R3156 T4088 T4086 arg1Of epilepticus,pilocarpine-induced
R3157 T4088 T4087 arg1Of epilepticus,status
R3158 T4089 T4090 arg1Of Diazepam,(
R3159 T4089 T4103 arg1Of Diazepam,was
R3160 T4089 T4104 arg2Of Diazepam,administered
R3161 T4089 T4112 arg2Of Diazepam,repeated
R3162 T4092 T4091 arg1Of mg/kg,10
R3163 T4092 T4093 arg1Of mg/kg,","
R3164 T4092 T4094 arg1Of mg/kg,i.p.
R3165 T4092 T4095 arg1Of mg/kg,;
R3166 T4095 T4090 arg2Of ;,(
R3167 T4098 T4096 arg1Of Roche,Hoffman
R3168 T4098 T4097 arg1Of Roche,Ia
R3169 T4098 T4099 arg1Of Roche,","
R3170 T4100 T4099 arg2Of Neuilly,","
R3171 T4101 T4095 arg2Of sur-Seine,;
R3172 T4101 T4098 arg1Of sur-Seine,Roche
R3173 T4101 T4100 arg1Of sur-Seine,Neuilly
R3174 T4102 T4090 arg3Of ),(
R3175 T4104 T4107 arg1Of administered,after
R3176 T4104 T4111 arg1Of administered,and
R3177 T4106 T4105 arg1Of hours,2
R3178 T4107 T4106 arg1Of after,hours
R3179 T4108 T4107 arg2Of onset,after
R3180 T4108 T4109 arg1Of onset,of
R3181 T4110 T4109 arg2Of SE,of
R3182 T4111 T4103 arg2Of and,was
R3183 T4111 T4113 arg1Of and,","
R3184 T4111 T4114 arg1Of and,as
R3185 T4112 T4111 arg2Of repeated,and
R3186 T4115 T4114 arg2Of needed,as
R3187 T4117 T4116 arg1Of rats,The
R3188 T4117 T4118 arg1Of rats,were
R3189 T4117 T4120 arg2Of rats,observed
R3190 T4120 T4118 arg2Of observed,were
R3191 T4120 T4119 arg1Of observed,then
R3192 T4120 T4127 arg1Of observed,in
R3193 T4124 T4120 arg3Of hours,observed
R3194 T4124 T4121 arg1Of hours,3
R3195 T4124 T4122 arg1Of hours,-
R3196 T4124 T4123 arg1Of hours,4
R3197 T4124 T4126 arg1Of hours,day
R3198 T4126 T4125 arg1Of day,a
R3199 T4129 T4127 arg2Of vivarium,in
R3200 T4129 T4128 arg1Of vivarium,the
R3201 T4129 T4130 arg1Of vivarium,for
R3202 T4132 T4131 arg1Of behavior,general
R3203 T4132 T4133 arg1Of behavior,and
R3204 T4133 T4130 arg2Of and,for
R3205 T4134 T4133 arg2Of occurrence,and
R3206 T4134 T4135 arg1Of occurrence,of
R3207 T4137 T4135 arg2Of seizures,of
R3208 T4137 T4136 arg1Of seizures,spontaneous
R3209 T4141 T4140 arg2Of non-SE,(
R3210 T4142 T4140 arg3Of ),(
R3211 T4143 T4138 arg1Of rats,Non-experienced
R3212 T4143 T4139 arg1Of rats,SE
R3213 T4143 T4140 arg1Of rats,(
R3214 T4143 T4144 arg1Of rats,(
R3215 T4143 T4160 arg1Of rats,and
R3216 T4145 T4144 arg2Of showing,(
R3217 T4145 T4150 arg1Of showing,during
R3218 T4149 T4145 arg2Of behaviors,showing
R3219 T4149 T4146 arg1Of behaviors,only
R3220 T4149 T4147 arg1Of behaviors,acute
R3221 T4149 T4148 arg1Of behaviors,seizure
R3222 T4151 T4150 arg2Of 10,during
R3223 T4151 T4152 arg1Of 10,-
R3224 T4154 T4152 arg2Of min,-
R3225 T4154 T4153 arg1Of min,30
R3226 T4154 T4155 arg1Of min,","
R3227 T4154 T4157 arg1Of min,=
R3228 T4156 T4155 arg2Of n,","
R3229 T4157 T4158 arg1Of =,8
R3230 T4159 T4144 arg3Of ),(
R3231 T4160 T4164 arg1Of and,were
R3232 T4160 T4165 arg2Of and,used
R3233 T4163 T4160 arg2Of rats,and
R3234 T4163 T4161 arg1Of rats,age-matched
R3235 T4163 T4162 arg1Of rats,normal
R3236 T4165 T4164 arg2Of used,were
R3237 T4165 T4166 arg1Of used,as
R3238 T4167 T4166 arg2Of controls,as
R3239 T4167 T4168 arg1Of controls,(
R3240 T4169 T4168 arg2Of n,(
R3241 T4169 T4170 arg1Of n,=
R3242 T4169 T4171 arg1Of n,7
R3243 T4172 T4168 arg3Of ),(

UBERON-AE

Id Subject Object Predicate Lexical cue
T3940 439-447 http://purl.obolibrary.org/obo/UBERON_0002102 denotes forelimb

GO-BP

Id Subject Object Predicate Lexical cue
T3954 1091-1094 http://purl.obolibrary.org/obo/GO_0007568 denotes age
T3953 469-479 http://purl.obolibrary.org/obo/GO_0046541 denotes salivation
T3952 1050-1059 http://purl.obolibrary.org/obo/GO_0007610 denotes behaviors
T3951 940-948 http://purl.obolibrary.org/obo/GO_0007610 denotes behavior
T3950 342-352 http://purl.obolibrary.org/obo/GO_0007610 denotes behavioral
T3949 229-239 http://purl.obolibrary.org/obo/GO_0007610 denotes behavioral

sentences

Id Subject Object Predicate Lexical cue
T3948 989-1145 Sentence denotes Non-experienced SE (non-SE) rats (showing only acute seizure behaviors during 10 - 30 min, n = 8) and age-matched normal rats were used as controls (n = 7).
T3947 866-988 Sentence denotes The rats were then observed 3 - 4 hours a day in the vivarium for general behavior and occurrence of spontaneous seizures.
T3946 735-865 Sentence denotes Diazepam (10 mg/kg, i.p.; Hoffman Ia Roche, Neuilly sur-Seine) was administered 2 hours after onset of SE and repeated, as needed.
T3945 522-734 Sentence denotes We applied the 2 hr-SE rat model, because > 90% of the rats that we monitored in our previous studies [25] displayed spontaneous, recurrent seizures within 1-3 months after pilocarpine-induced status epilepticus.
T3944 283-521 Sentence denotes Approximately 80% of pilocarpine treated rats showed acute behavioral features of SE (including akinesia, facial automatisms, limbic seizures consisting of forelimb clonus with rearing, salivation, masticatory jaw movements, and falling).
T3943 198-282 Sentence denotes Using this treatment paradigm, behavioral seizures typically began within 20-40 min.
T3942 0-197 Sentence denotes Three days after surgery, rats were treated with pilocarpine (380 mg/kg, i.p.; Sigma-Aldrich Co., St. Louis, MO) at 20 min after methylscopolamine (5 mg/kg, i.p.; Sigma-Aldrich Co., St. Louis, MO).
T67 0-197 Sentence denotes Three days after surgery, rats were treated with pilocarpine (380 mg/kg, i.p.; Sigma-Aldrich Co., St. Louis, MO) at 20 min after methylscopolamine (5 mg/kg, i.p.; Sigma-Aldrich Co., St. Louis, MO).
T68 198-282 Sentence denotes Using this treatment paradigm, behavioral seizures typically began within 20-40 min.
T69 283-521 Sentence denotes Approximately 80% of pilocarpine treated rats showed acute behavioral features of SE (including akinesia, facial automatisms, limbic seizures consisting of forelimb clonus with rearing, salivation, masticatory jaw movements, and falling).
T70 522-734 Sentence denotes We applied the 2 hr-SE rat model, because > 90% of the rats that we monitored in our previous studies [25] displayed spontaneous, recurrent seizures within 1-3 months after pilocarpine-induced status epilepticus.
T71 735-865 Sentence denotes Diazepam (10 mg/kg, i.p.; Hoffman Ia Roche, Neuilly sur-Seine) was administered 2 hours after onset of SE and repeated, as needed.
T72 866-988 Sentence denotes The rats were then observed 3 - 4 hours a day in the vivarium for general behavior and occurrence of spontaneous seizures.
T73 989-1145 Sentence denotes Non-experienced SE (non-SE) rats (showing only acute seizure behaviors during 10 - 30 min, n = 8) and age-matched normal rats were used as controls (n = 7).

ICD10

Id Subject Object Predicate Lexical cue
T3956 715-733 http://purl.bioontology.org/ontology/ICD10/G41 denotes status epilepticus
T3955 715-733 http://purl.bioontology.org/ontology/ICD10/G41.9 denotes status epilepticus

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T4408 835-840 Protein denotes of SE
T4407 1138-1141 Entity denotes n =
T4406 49-72 Entity denotes pilocarpine (380 mg/kg,
T4405 1075-1083 Entity denotes min, n =
T4404 735-754 Entity denotes Diazepam (10 mg/kg,
T4403 73-97 Protein denotes i.p.; Sigma-Aldrich Co.,
T4402 365-367 Entity denotes SE
T4401 735-759 Protein denotes Diazepam (10 mg/kg, i.p.
T4400 1005-1016 Protein denotes SE (non-SE)
T4399 157-181 Protein denotes i.p.; Sigma-Aldrich Co.,
T4398 695-714 Entity denotes pilocarpine-induced
T4397 301-323 Entity denotes of pilocarpine treated
T4396 283-323 Entity denotes Approximately 80% of pilocarpine treated

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T4395 1144-1145 . denotes .
T4394 1143-1144 -RRB- denotes )
T4393 1142-1143 CD denotes 7
T4392 1140-1141 SYM denotes =
T4391 1138-1139 FW denotes n
T4390 1137-1138 -LRB- denotes (
T4389 1128-1136 NNS denotes controls
T4388 1125-1127 IN denotes as
T4387 1120-1124 VBN denotes used
T4386 1115-1119 VBD denotes were
T4385 1110-1114 NNS denotes rats
T4384 1103-1109 JJ denotes normal
T4383 1091-1102 JJ denotes age-matched
T4382 1087-1090 CC denotes and
T4381 1085-1086 -RRB- denotes )
T4380 1084-1085 CD denotes 8
T4379 1082-1083 SYM denotes =
T4378 1080-1081 NN denotes n
T4377 1078-1079 , denotes ,
T4376 1075-1078 NN denotes min
T4375 1072-1074 CD denotes 30
T4374 1070-1071 : denotes -
T4373 1067-1069 CD denotes 10
T4372 1060-1066 IN denotes during
T4371 1050-1059 NNS denotes behaviors
T4370 1042-1049 NN denotes seizure
T4369 1036-1041 JJ denotes acute
T4368 1031-1035 RB denotes only
T4367 1023-1030 VBG denotes showing
T4366 1022-1023 -LRB- denotes (
T4365 1017-1021 NNS denotes rats
T4364 1015-1016 -RRB- denotes )
T4363 1009-1015 JJ denotes non-SE
T4362 1008-1009 -LRB- denotes (
T4361 1005-1007 NNP denotes SE
T4360 989-1004 JJ denotes Non-experienced
T4359 987-988 . denotes .
T4358 979-987 NNS denotes seizures
T4357 967-978 JJ denotes spontaneous
T4356 964-966 IN denotes of
T4355 953-963 NN denotes occurrence
T4354 949-952 CC denotes and
T4353 940-948 NN denotes behavior
T4352 932-939 JJ denotes general
T4351 928-931 IN denotes for
T4350 919-927 NN denotes vivarium
T4349 915-918 DT denotes the
T4348 912-914 IN denotes in
T4347 908-911 NN denotes day
T4346 906-907 DT denotes a
T4345 900-905 NNS denotes hours
T4344 898-899 CD denotes 4
T4343 896-897 : denotes -
T4342 894-895 LS denotes 3
T4341 885-893 VBN denotes observed
T4340 880-884 RB denotes then
T4339 875-879 VBD denotes were
T4338 870-874 NNS denotes rats
T4337 866-869 DT denotes The
T4336 864-865 . denotes .
T4335 858-864 VBN denotes needed
T4334 855-857 IN denotes as
T4333 853-854 , denotes ,
T4332 845-853 VBN denotes repeated
T4331 841-844 CC denotes and
T4330 838-840 NNP denotes SE
T4329 835-837 IN denotes of
T4328 829-834 NN denotes onset
T4327 823-828 IN denotes after
T4326 817-822 NNS denotes hours
T4325 815-816 CD denotes 2
T4324 802-814 VBN denotes administered
T4323 798-801 VBD denotes was
T4322 796-797 -RRB- denotes )
T4321 787-796 NNP denotes sur-Seine
T4320 779-786 NNP denotes Neuilly
T4319 777-778 , denotes ,
T4318 772-777 NNP denotes Roche
T4317 769-771 NNP denotes Ia
T4316 761-768 NNP denotes Hoffman
T4315 759-760 : denotes ;
T4314 755-759 NN denotes i.p.
T4313 753-754 , denotes ,
T4312 748-753 NN denotes mg/kg
T4311 745-747 CD denotes 10
T4310 744-745 -LRB- denotes (
T4309 735-743 NN denotes Diazepam
T4308 733-734 . denotes .
T4307 722-733 NN denotes epilepticus
T4306 715-721 NN denotes status
T4305 695-714 JJ denotes pilocarpine-induced
T4304 689-694 IN denotes after
T4303 682-688 NNS denotes months
T4302 678-681 JJ denotes 1-3
T4301 671-677 IN denotes within
T4300 662-670 NNS denotes seizures
T4299 652-661 JJ denotes recurrent
T4298 650-651 , denotes ,
T4297 639-650 JJ denotes spontaneous
T4296 629-638 VBD denotes displayed
T4295 627-628 NNP denotes ]
T4294 625-627 CD denotes 25
T4293 624-625 NNP denotes [
T4292 616-623 NNS denotes studies
T4291 607-615 JJ denotes previous
T4290 603-606 PRP$ denotes our
T4289 600-602 IN denotes in
T4288 590-599 VBD denotes monitored
T4287 587-589 PRP denotes we
T4286 582-586 IN denotes that
T4285 577-581 NNS denotes rats
T4284 573-576 DT denotes the
T4283 570-572 IN denotes of
T4282 568-569 NN denotes %
T4281 566-568 CD denotes 90
T4280 564-565 CD denotes >
T4279 556-563 IN denotes because
T4278 554-555 , denotes ,
T4277 549-554 NN denotes model
T4276 545-548 NN denotes rat
T4275 539-544 JJ denotes hr-SE
T4274 537-538 CD denotes 2
T4273 533-536 DT denotes the
T4272 525-532 VBD denotes applied
T4271 522-524 PRP denotes We
T4270 520-521 . denotes .
T4269 519-520 -RRB- denotes )
T4268 512-519 VBG denotes falling
T4267 508-511 CC denotes and
T4266 506-507 , denotes ,
T4265 497-506 NNS denotes movements
T4264 493-496 NN denotes jaw
T4263 481-492 JJ denotes masticatory
T4262 479-480 , denotes ,
T4261 469-479 NN denotes salivation
T4260 467-468 , denotes ,
T4259 460-467 NN denotes rearing
T4258 455-459 IN denotes with
T4257 448-454 NN denotes clonus
T4256 439-447 NN denotes forelimb
T4255 436-438 IN denotes of
T4254 425-435 VBG denotes consisting
T4253 416-424 NNS denotes seizures
T4252 409-415 JJ denotes limbic
T4251 407-408 , denotes ,
T4250 396-407 NNS denotes automatisms
T4249 389-395 JJ denotes facial
T4248 387-388 , denotes ,
T4247 379-387 NN denotes akinesia
T4246 369-378 VBG denotes including
T4245 368-369 -LRB- denotes (
T4187 66-71 NN denotes mg/kg
T4186 62-65 CD denotes 380
T4185 61-62 -LRB- denotes (
T4184 49-60 NN denotes pilocarpine
T4183 44-48 IN denotes with
T4182 36-43 VBN denotes treated
T4181 31-35 VBD denotes were
T4180 26-30 NNS denotes rats
T4179 24-25 , denotes ,
T4178 17-24 NN denotes surgery
T4177 11-16 IN denotes after
T4176 6-10 NNS denotes days
T4175 0-5 CD denotes Three
T4244 365-367 NNP denotes SE
T4243 362-364 IN denotes of
T4242 353-361 NNS denotes features
T4241 342-352 JJ denotes behavioral
T4240 336-341 JJ denotes acute
T4239 329-335 VBD denotes showed
T4238 324-328 NNS denotes rats
T4237 316-323 VBN denotes treated
T4236 304-315 NN denotes pilocarpine
T4235 301-303 IN denotes of
T4234 299-300 NN denotes %
T4233 297-299 CD denotes 80
T4232 283-296 RB denotes Approximately
T4231 281-282 . denotes .
T4230 278-281 NN denotes min
T4229 272-277 CD denotes 20-40
T4228 265-271 IN denotes within
T4227 259-264 VBD denotes began
T4226 249-258 RB denotes typically
T4225 240-248 NNS denotes seizures
T4224 229-239 JJ denotes behavioral
T4223 227-228 , denotes ,
T4222 219-227 NN denotes paradigm
T4221 209-218 NN denotes treatment
T4220 204-208 DT denotes this
T4219 198-203 VBG denotes Using
T4218 196-197 . denotes .
T4217 195-196 -RRB- denotes )
T4216 193-195 NNP denotes MO
T4215 191-192 , denotes ,
T4214 186-191 NNP denotes Louis
T4213 182-185 NNP denotes St.
T4212 180-181 , denotes ,
T4211 177-180 NNP denotes Co.
T4210 163-176 NNP denotes Sigma-Aldrich
T4209 161-162 : denotes ;
T4208 157-161 NN denotes i.p.
T4207 155-156 , denotes ,
T4206 150-155 NN denotes mg/kg
T4205 148-149 CD denotes 5
T4204 147-148 -LRB- denotes (
T4203 129-146 NN denotes methylscopolamine
T4202 123-128 IN denotes after
T4201 119-122 NN denotes min
T4200 116-118 CD denotes 20
T4199 113-115 IN denotes at
T4198 111-112 -RRB- denotes )
T4197 109-111 NNP denotes MO
T4196 107-108 , denotes ,
T4195 102-107 NNP denotes Louis
T4194 98-101 NNP denotes St.
T4193 96-97 , denotes ,
T4192 93-96 NNP denotes Co.
T4191 79-92 NNP denotes Sigma-Aldrich
T4190 77-78 : denotes ;
T4189 73-77 NN denotes i.p.
T4188 71-72 , denotes ,
R3246 T4175 T4176 nummod Three,days
R3247 T4176 T4177 npadvmod days,after
R3249 T4178 T4177 pobj surgery,after
R3250 T4179 T4182 punct ",",treated
R3251 T4180 T4182 nsubjpass rats,treated
R3252 T4181 T4182 auxpass were,treated
R3253 T4182 T4182 ROOT treated,treated
R3254 T4183 T4182 prep with,treated
R3255 T4184 T4183 pobj pilocarpine,with
R3256 T4185 T4184 punct (,pilocarpine
R3257 T4186 T4187 nummod 380,mg/kg
R3258 T4187 T4184 appos mg/kg,pilocarpine
R3259 T4188 T4184 punct ",",pilocarpine
R3260 T4189 T4184 conj i.p.,pilocarpine
R3261 T4190 T4192 punct ;,Co.
R3262 T4191 T4192 compound Sigma-Aldrich,Co.
R3263 T4192 T4182 npadvmod Co.,treated
R3264 T4193 T4192 punct ",",Co.
R3265 T4194 T4195 compound St.,Louis
R3266 T4195 T4192 npadvmod Louis,Co.
R3267 T4196 T4192 punct ",",Co.
R3268 T4197 T4192 appos MO,Co.
R3269 T4198 T4192 punct ),Co.
R3270 T4199 T4192 prep at,Co.
R3271 T4200 T4201 nummod 20,min
R3272 T4201 T4199 pobj min,at
R3273 T4202 T4201 prep after,min
R3274 T4203 T4202 pobj methylscopolamine,after
R3275 T4204 T4203 punct (,methylscopolamine
R3276 T4205 T4206 nummod 5,mg/kg
R3277 T4206 T4203 appos mg/kg,methylscopolamine
R3278 T4207 T4206 punct ",",mg/kg
R3279 T4208 T4206 conj i.p.,mg/kg
R3280 T4209 T4192 punct ;,Co.
R3281 T4210 T4211 compound Sigma-Aldrich,Co.
R3282 T4211 T4192 conj Co.,Co.
R3283 T4212 T4211 punct ",",Co.
R3284 T4213 T4214 compound St.,Louis
R3285 T4214 T4211 npadvmod Louis,Co.
R3286 T4215 T4211 punct ",",Co.
R3287 T4216 T4192 npadvmod MO,Co.
R3288 T4217 T4192 punct ),Co.
R3289 T4218 T4182 punct .,treated
R3290 T4219 T4227 advcl Using,began
R3291 T4220 T4222 det this,paradigm
R3292 T4221 T4222 compound treatment,paradigm
R3293 T4222 T4219 dobj paradigm,Using
R3294 T4223 T4227 punct ",",began
R3295 T4224 T4225 amod behavioral,seizures
R3296 T4225 T4227 nsubj seizures,began
R3297 T4226 T4227 advmod typically,began
R3298 T4227 T4227 ROOT began,began
R3299 T4228 T4227 prep within,began
R3300 T4229 T4230 nummod 20-40,min
R3301 T4230 T4228 pobj min,within
R3302 T4231 T4227 punct .,began
R3303 T4232 T4233 advmod Approximately,80
R3304 T4233 T4234 nummod 80,%
R3305 T4234 T4239 nsubj %,showed
R3306 T4235 T4234 prep of,%
R3307 T4236 T4237 advmod pilocarpine,treated
R3308 T4237 T4238 amod treated,rats
R3309 T4238 T4235 pobj rats,of
R3310 T4239 T4239 ROOT showed,showed
R3311 T4240 T4242 amod acute,features
R3312 T4241 T4242 amod behavioral,features
R3313 T4242 T4239 dobj features,showed
R3314 T4243 T4242 prep of,features
R3315 T4244 T4243 pobj SE,of
R3316 T4245 T4246 punct (,including
R3317 T4246 T4242 prep including,features
R3318 T4247 T4246 pobj akinesia,including
R3319 T4248 T4247 punct ",",akinesia
R3320 T4249 T4250 amod facial,automatisms
R3321 T4250 T4247 conj automatisms,akinesia
R3322 T4251 T4250 punct ",",automatisms
R3323 T4252 T4253 amod limbic,seizures
R3324 T4253 T4250 conj seizures,automatisms
R3325 T4254 T4253 acl consisting,seizures
R3326 T4255 T4254 prep of,consisting
R3327 T4256 T4257 compound forelimb,clonus
R3328 T4257 T4255 pobj clonus,of
R3329 T4258 T4254 prep with,consisting
R3330 T4259 T4258 pobj rearing,with
R3331 T4260 T4259 punct ",",rearing
R3332 T4261 T4259 conj salivation,rearing
R3333 T4262 T4261 punct ",",salivation
R3334 T4263 T4265 amod masticatory,movements
R3335 T4264 T4265 compound jaw,movements
R3336 T4265 T4261 conj movements,salivation
R3337 T4266 T4265 punct ",",movements
R3338 T4267 T4265 cc and,movements
R3339 T4268 T4265 conj falling,movements
R3340 T4269 T4239 punct ),showed
R3341 T4270 T4239 punct .,showed
R3342 T4271 T4272 nsubj We,applied
R3343 T4272 T4272 ROOT applied,applied
R3344 T4273 T4277 det the,model
R3345 T4274 T4277 nummod 2,model
R3346 T4275 T4277 amod hr-SE,model
R3347 T4276 T4277 compound rat,model
R3348 T4277 T4272 dobj model,applied
R3349 T4278 T4272 punct ",",applied
R3350 T4279 T4296 mark because,displayed
R3351 T4280 T4282 nummod >,%
R3352 T4281 T4282 nummod 90,%
R3353 T4282 T4296 nsubj %,displayed
R3354 T4283 T4282 prep of,%
R3355 T4284 T4285 det the,rats
R3356 T4285 T4283 pobj rats,of
R3357 T4286 T4288 dobj that,monitored
R3358 T4287 T4288 nsubj we,monitored
R3359 T4288 T4285 relcl monitored,rats
R3360 T4289 T4288 prep in,monitored
R3361 T4290 T4292 poss our,studies
R3362 T4291 T4292 amod previous,studies
R3363 T4292 T4289 pobj studies,in
R3364 T4293 T4295 nmod [,]
R3365 T4294 T4295 nummod 25,]
R3366 T4295 T4296 nsubj ],displayed
R3367 T4296 T4272 advcl displayed,applied
R3368 T4297 T4300 amod spontaneous,seizures
R3369 T4298 T4300 punct ",",seizures
R3370 T4299 T4300 amod recurrent,seizures
R3371 T4300 T4296 dobj seizures,displayed
R3372 T4301 T4300 prep within,seizures
R3373 T4302 T4303 amod 1-3,months
R3374 T4303 T4301 pobj months,within
R3375 T4304 T4296 prep after,displayed
R3376 T4305 T4307 amod pilocarpine-induced,epilepticus
R3377 T4306 T4307 compound status,epilepticus
R3378 T4307 T4304 pobj epilepticus,after
R3379 T4308 T4272 punct .,applied
R3380 T4309 T4309 ROOT Diazepam,Diazepam
R3381 T4310 T4309 punct (,Diazepam
R3382 T4311 T4312 nummod 10,mg/kg
R3383 T4312 T4309 appos mg/kg,Diazepam
R3384 T4313 T4314 punct ",",i.p.
R3385 T4314 T4312 conj i.p.,mg/kg
R3386 T4315 T4309 punct ;,Diazepam
R3387 T4316 T4318 compound Hoffman,Roche
R3388 T4317 T4318 compound Ia,Roche
R3389 T4318 T4324 nsubjpass Roche,administered
R3390 T4319 T4318 punct ",",Roche
R3391 T4320 T4321 compound Neuilly,sur-Seine
R3392 T4321 T4318 appos sur-Seine,Roche
R3393 T4322 T4318 punct ),Roche
R3394 T4323 T4324 auxpass was,administered
R3395 T4324 T4324 ROOT administered,administered
R3396 T4325 T4326 nummod 2,hours
R3397 T4326 T4327 npadvmod hours,after
R3398 T4327 T4324 prep after,administered
R3399 T4328 T4327 pobj onset,after
R3400 T4329 T4328 prep of,onset
R3401 T4330 T4329 pobj SE,of
R3402 T4331 T4324 cc and,administered
R3403 T4332 T4324 conj repeated,administered
R3404 T4333 T4332 punct ",",repeated
R3405 T4334 T4335 mark as,needed
R3406 T4335 T4332 advcl needed,repeated
R3407 T4336 T4324 punct .,administered
R3408 T4337 T4338 det The,rats
R3409 T4338 T4341 nsubjpass rats,observed
R3410 T4339 T4341 auxpass were,observed
R3411 T4340 T4341 advmod then,observed
R3412 T4341 T4341 ROOT observed,observed
R3413 T4342 T4345 nummod 3,hours
R3414 T4343 T4344 punct -,4
R3415 T4344 T4345 nummod 4,hours
R3416 T4345 T4341 dobj hours,observed
R3417 T4346 T4347 det a,day
R3418 T4347 T4345 npadvmod day,hours
R3419 T4348 T4341 prep in,observed
R3420 T4349 T4350 det the,vivarium
R3421 T4350 T4348 pobj vivarium,in
R3422 T4351 T4341 prep for,observed
R3423 T4352 T4353 amod general,behavior
R3424 T4353 T4351 pobj behavior,for
R3425 T4354 T4353 cc and,behavior
R3463 T4392 T4393 punct =,7
R3464 T4393 T4391 prep 7,n
R3465 T4394 T4389 punct ),controls
R3466 T4395 T4387 punct .,used
R3426 T4355 T4353 conj occurrence,behavior
R3427 T4356 T4353 prep of,behavior
R3428 T4357 T4358 amod spontaneous,seizures
R3429 T4358 T4356 pobj seizures,of
R3430 T4359 T4341 punct .,observed
R3431 T4360 T4361 amod Non-experienced,SE
R3432 T4361 T4365 nmod SE,rats
R3433 T4362 T4363 punct (,non-SE
R3434 T4363 T4361 amod non-SE,SE
R3435 T4364 T4363 punct ),non-SE
R3436 T4365 T4387 nsubjpass rats,used
R3437 T4366 T4367 punct (,showing
R3438 T4367 T4365 acl showing,rats
R3439 T4368 T4371 advmod only,behaviors
R3440 T4369 T4371 amod acute,behaviors
R3441 T4370 T4371 compound seizure,behaviors
R3442 T4371 T4367 dobj behaviors,showing
R3443 T4372 T4367 prep during,showing
R3444 T4373 T4376 nummod 10,min
R3445 T4374 T4375 punct -,30
R3446 T4375 T4373 prep 30,10
R3447 T4376 T4372 pobj min,during
R3448 T4377 T4380 punct ",",8
R3449 T4378 T4380 nmod n,8
R3450 T4379 T4380 punct =,8
R3451 T4380 T4367 npadvmod 8,showing
R3452 T4381 T4380 punct ),8
R3453 T4382 T4380 cc and,8
R3454 T4383 T4385 amod age-matched,rats
R3455 T4384 T4385 amod normal,rats
R3456 T4385 T4387 nsubjpass rats,used
R3457 T4386 T4387 auxpass were,used
R3458 T4387 T4387 ROOT used,used
R3459 T4388 T4387 prep as,used
R3460 T4389 T4388 pobj controls,as
R3461 T4390 T4389 punct (,controls
R3462 T4391 T4389 appos n,controls